NCCN Guidelines® Insights Bone Cancer, Version 2.2017 Featured Updates to the NCCN Guidelines

被引：213

作者：

Biermann, J. Sybil ^{[1
]}

Chow, Warren ^{[2
]}

Reed, Damon R. ^{[3
]}

Lucas, David ^{[1
]}

Adkins, Douglas R. ^{[4
,5
]}

Agulnik, Mark ^{[6
]}

Benjamin, Robert S. ^{[7
]}

Brigman, Brian ^{[8
]}

Budd, G. Thomas ^{[9
,10
]}

Curry, William T. ^{[11
]}

Didwania, Aarati ^{[6
]}

Fabbri, Nicola ^{[12
]}

Hornicek, Francis J. ^{[11
]}

Kuechle, Joseph B. ^{[13
]}

Lindskog, Dieter ^{[14
]}

Mayerson, Joel ^{[15
]}

McGarry, Sean V. ^{[16
]}

Million, Lynn ^{[17
]}

Morris, Carol D. ^{[18
]}

Movva, Sujana ^{[19
]}

O'Donnell, Richard J. ^{[20
]}

Randall, R. Lor ^{[21
]}

Rose, Peter ^{[22
]}

Santana, Victor M. ^{[23
]}

Satcher, Robert L.

Schwartz, Herbert ^{[24
]}

Siegel, Herrick J. ^{[25
]}

Thornton, Katherine ^{[26
]}

Villalobos, Victor ^{[27
]}

Bergman, Mary Anne ^{[28
]}

Scavone, Jillian L. ^{[28
]}

机构：

[1] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA

[2] City Hope Comprehens Canc Ctr, Duarte, CA USA

[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[4] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO USA

[5] Washington Univ, Sch Med, St Louis, MO 63130 USA

[6] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[7] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[8] Duke Canc Inst, Durham, NC USA

[9] Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA

[10] Taussig Canc Inst, Cleveland Clin, Cleveland, OH USA

[11] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA

[12] Mem Sloan Kettering Canc Ctr, New Rochelle, NY USA

[13] Roswell Pk Canc Inst, Buffalo, NY 14263 USA

[14] Smilow Canc Hosp, Yale Canc Ctr, New Haven, CT USA

[15] Ohio State Univ, James Canc Hosp & Solove Res Inst, Ctr Comprehens Canc, Columbus, OH 43210 USA

[16] Fred Pamela Buffett Canc Ctr, Omaha, NE USA

[17] Stanford Canc Inst, Stanford, CA USA

[18] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[19] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA

[20] UCSF, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[21] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[22] Mayo Clin, Canc Ctr, Rochester, MN USA

[23] Univ Tennessee, St Jude Childrens Res Hosp, Hlth Sci Ctr, Knoxville, TN 37996 USA

[24] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[25] Univ Alabama Birmingham, Ctr Comprehens Canc, Tuscaloosa, AL 35487 USA

[26] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[27] Univ Colorado, Ctr Canc, Boulder, CO 80309 USA

[28] Natl Comprehens Canc Network, Seattle, WA USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2017年 / 15卷 / 02期

关键词：

LOCALIZED EWING-SARCOMA; SARCOMA/PRIMITIVE NEUROECTODERMAL TUMOR; PROGNOSTIC-FACTORS; NEOADJUVANT CHEMOTHERAPY; STANDARD CHEMOTHERAPY; MULTIMODAL THERAPY; SINGLE-INSTITUTION; PEDIATRIC-PATIENTS; FRENCH-SOCIETY; YOUNG-ADULTS;

D O I：

10.6004/jnccn.2017.0017

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The NCCN Guidelines for Bone Cancer provide interdisciplinary recommendations for treating chordoma, chondrosarcoma, giant cell tumor of bone, Ewing sarcoma, and osteosarcoma. These NCCN Guidelines Insights summarize the NCCN Bone Cancer Panel's guideline recommendations for treating Ewing sarcoma. The data underlying these treatment recommendations are also discussed.

引用

页码：155 / 167

页数：13

共 81 条

[1]

Ahrens S, 1999, MED PEDIATR ONCOL, V32, P186, DOI 10.1002/(SICI)1096-911X(199903)32:3<186::AID-MPO5>3.0.CO

[2]

2-D

[3]

Andrassy RJ, 2003, ANN SURG, V238, P567

[4]

[Anonymous], SEER CANC STAT FACT

[5]

Bacci G, 1998, CANCER-AM CANCER SOC, V82, P1174, DOI 10.1002/(SICI)1097-0142(19980315)82:6<1174::AID-CNCR24>3.0.CO

[6]

2-2

[7] Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992 [J].

Bacci, G ;

Forni, C ;

Longhi, A ;

Ferrari, S ;

Donati, D ;

De Paolis, M ;

Barbieri, E ;

Pignotti, E ;

Rosito, P ;

Versari, M .

EUROPEAN JOURNAL OF CANCER, 2004, 40 (01) :73-83

[8] Therapy and survival after recurrence of Ewing's tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997 [J].

Bacci, G ;

Ferrari, S ;

Longhi, A ;

Donati, D ;

De Paolis, M ;

Forni, C ;

Versari, M ;

Setola, E ;

Briccoli, A ;

Barbieri, E .

ANNALS OF ONCOLOGY, 2003, 14 (11) :1654-1659

[9] Prognostic factors in non-metastatic Ewing's sarcoma tumor of bone: An analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998 [J].

Bacci, Gaetano ;

Longhi, Alessandra ;

Ferrari, Stefano ;

Mercuri, Mario ;

Versari, Michela ;

Bertoni, Franco .

ACTA ONCOLOGICA, 2006, 45 (04) :469-475

[10] Treatment of nonmetastatic Ewing's sarcoma family tumors of the spine and sacrum: the experience from a single institution [J].

Bacci, Gaetano ;

Boriani, Stefano ;

Balladelli, Alba ;

Barbieri, Enza ;

Longhi, Alessandra ;

Alberghini, Marco ;

Scotlandi, Katia ;

Forni, Cristiana ;

Pollastri, Paola ;

Vanel, Daniel ;

Mercuri, Mario .

EUROPEAN SPINE JOURNAL, 2009, 18 (08) :1091-1095

← 1 2 3 4 5 6 7 8 9 →